Financial & competing interests disclosure
M Carbone has a pending patent application on BAP1. This work was supported by NCI R01 and P01 (to M Carbone), the UH Foundation (to M Carbone); NCI R01, the Mesothelioma Applied Research Foundation and the Riviera United-4 a CURE (to H Yang) and UL1 RR024153-04 (to LK Ferris). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.